FADD overexpression has been observed in head and neck squamous cell carcinoma, breast cancer, lung cancer and early-stage glottic squamous cell carcinoma and correlates with poor survival rate [12, 14–16, 25, 26]. This evidence concerns the gene FADD and head and neck squamous cell carcinoma.